1,262
Views
2
CrossRef citations to date
0
Altmetric
Editorial

The Role of Anti-IL-1 Treatment in MIS-C Patients

, , , &
Pages 1-5 | Received 05 May 2021, Accepted 11 Nov 2021, Published online: 26 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fabrizio Martora, Matteo Megna, Teresa Battista, Luca Potestio, Maria Carmela Annunziata, Claudio Marasca, Alessia Villani & Gabriella Fabbrocini. (2023) Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience. Clinical, Cosmetic and Investigational Dermatology 16, pages 135-148.
Read now

Articles from other publishers (1)

Elnaz Khani, Marzieh Shahrabi, Haleh Rezaei, Fariba Pourkarim, Hoda Afsharirad & Mohammad Solduzian. (2022) Current evidence on the use of anakinra in COVID-19. International Immunopharmacology 111, pages 109075.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.